Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Steroid bill gains strength

This article was originally published in The Tan Sheet

Executive Summary

Senate passes Anabolic Steroid Control Act of 2004 (S 2195) by unanimous consent Oct. 6. The bill, which makes a number of steroid precursors controlled substances, will now head to conference; the House passed a similar measure in June (1"The Tan Sheet" June 7, 2004, p. 13). The bill was stripped of a provision sought by Sen. Richard Durbin (D-Ill.) in September that would have required mandatory adverse event reporting in the Senate judiciary committee (2"The Tan Sheet" Oct. 4, 2004, In Brief)...
Advertisement

Related Content

Anabolic Steroid Act Heads To Senate After Clearing House 408-3
Anabolic Steroid Act Heads To Senate After Clearing House 408-3

Topics

Advertisement
UsernamePublicRestriction

Register

PS097389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel